3rd-Party Payor Class Nixed In Lilly Zyprexa Appeal
A federal appeals court reversed an order Friday that granted class certification to a group of insurers, labor unions and pension funds that say they overpaid for the antipsychotic drug Zyprexa...To view the full article, register now.
Already a subscriber? Click here to view full article